The mechanistic basis linking cytokine storm to thrombosis in COVID-19.
COVID-19
Clots
Coagulopathy
Cytokine storm
SARS-CoV2
Thrombosis
Journal
Thrombosis update
ISSN: 2666-5727
Titre abrégé: Thromb Update
Pays: England
ID NLM: 9918249114406676
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
01
02
2022
revised:
26
04
2022
accepted:
09
05
2022
medline:
1
8
2022
pubmed:
1
8
2022
entrez:
15
4
2024
Statut:
ppublish
Résumé
It is now well established that infection with SARS-CoV-2 resulting in COVID-19 disease includes a severely symptomatic subset of patients in whom an aggressive and/or dysregulated host immune response leads to cytokine storm syndrome (CSS) that may be further complicated by thrombotic events, contributing to the severe morbidity and mortality observed in COVID-19. This review provides a brief overview of cytokine storm in COVID-19, and then presents a mechanistic discussion of how cytokine storm affects integrated pathways in thrombosis involving the endothelium, platelets, the coagulation cascade, eicosanoids, auto-antibody mediated thrombosis, and the fibrinolytic system.
Identifiants
pubmed: 38620974
doi: 10.1016/j.tru.2022.100110
pii: S2666-5727(22)00014-1
pmc: PMC9116969
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100110Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.